Pneumocytis carinii is a opportunistic parasite that causes pneumonia leading to the deaths of many immunocompromised hosts, such as AIDS patients. Current knowledge of the biochemistry, cellular and molecular biology of the organism is limited; the major reason being that there is yet no axenic continuous cultivation methods for this organism. Parasites, however, can be obtained from lungs of infected mammals and separated from contaminating host cells and microbes. Growth of P. carinii with tissue culture cells has been described by several investigators. Up to three serial transfers, each with about a 3-fold increase in cell densities, have been achieved. Recently, limited growth of the organism in axenic culture has been accomplished. This project is aimed at gaining more information concerning the lipids of P. carinii. Pneumocystis lives in a relatively hydrophobic environment that is rich in lung surfactant proteins and phospholipids (mainly dipalmitoyl phosphatidylcholine). There is very little reported on the direct biochemical characterizations of the lipids of Pneumocystis. We plan to systematically characterize these compounds in detail by a variety of biochemical and biophysical procedures. Individual lipid components will be separated and purified by this-layer, column, high performance and gas-liquid chromatographic procedures. The moieties of complex lipids will be released by hydrolysis, separated by chemical and enzymatic procedures and each will be characterized. Definitive characterizations and identifications will be done by high resolution mass spectrometry and fast atom bombardment mass spectrometry. In the event that lipids, significantly different from those synthesized by the host, are identified, these will be considered potential targets for the development of drugs designed for the elimination of the parasite from the host. The lipid composition of P. carinii will be altered by growing the organisms in culture with or without feeder cells in the presence of inhibitors of lipid metabolism or with a variety of lipids and precursor compounds. Cells in culture with and without supplementation will be compared for their relative sensitivities to drugs. These studies, directed at elucidating the lipid composition, are expected to provide insight into the nutrition of P. Carinii. This information should be useful for the eventual formulation of continuous axenic culture media for the organism which in turn would greatly facilitate further biochemical studies as well as drug testing which should eventually lead to the development of better drugs to cure this parasitic infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI029316-03
Application #
3144063
Study Section
Special Emphasis Panel (ARR (V4))
Project Start
1989-11-01
Project End
1994-10-31
Budget Start
1991-11-01
Budget End
1992-10-31
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Type
Schools of Arts and Sciences
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Wyder, Michael A; Johnston, Laura Q; Kaneshiro, Edna S (2010) Evidence for DNA synthesis in Pneumocystis carinii trophozoites treated with the beta-1,3-glucan synthesis inhibitor pneumocandin L-693,989. J Eukaryot Microbiol 57:447-8
Basselin, Mireille; Hunt, Shannon M; Abdala-Valencia, Hiam et al. (2005) Ubiquinone synthesis in mitochondrial and microsomal subcellular fractions of Pneumocystis spp.: differential sensitivities to atovaquone. Eukaryot Cell 4:1483-92
Giner, Jose-Luis; Zhao, Hui; Amit, Zunika et al. (2004) Sterol composition of Pneumocystis jirovecii with blocked 14alpha-demethylase activity. J Eukaryot Microbiol 51:634-43
Kaneshiro, Edna S (2004) Sterol metabolism in the opportunistic pathogen Pneumocystis: advances and new insights. Lipids 39:753-61
Kaneshiro, Edna S; Basselin, Mireille; Hunt, Shannon M (2003) Evidence that biosynthesis of individual ubiquinone homologs in Pneumocystis carinii is under homolog-specific negative feedback (product) control. J Eukaryot Microbiol 50 Suppl:622-3
Zhao, Hui; Giner, Jose-Luis; Kaneshiro, Edna S (2003) Definitive structural identities of Pneumocystis jirovecii sterols. J Eukaryot Microbiol 50 Suppl:680
Worsham, D Nicole; Basselin, Mireille; Smulian, A George et al. (2003) Evidence for cholesterol scavenging by Pneumocystis and potential modifications of host-synthesized sterols by the P. carinii SAM:SMT. J Eukaryot Microbiol 50 Suppl:678-9
Giner, Jose-Luis; Zhao, Hui; Beach, David H et al. (2002) Comprehensive and definitive structural identities of Pneumocystis carinii sterols. J Lipid Res 43:1114-24
Kaneshiro, Edna S; Rosenfeld, Jill A; Basselin-Eiweida, Mireille et al. (2002) The Pneumocystis carinii drug target S-adenosyl-L-methionine:sterol C-24 methyl transferase has a unique substrate preference. Mol Microbiol 44:989-99
Kaneshiro, Edna S (2002) Is Pneumocystis a plant? J Eukaryot Microbiol 49:367-73

Showing the most recent 10 out of 54 publications